Mesoblast and BMT CTN to initiate pivotal trial of Ryoncil®
Go back to Newsroom
Mesoblast and BMT CTN to initiate pivotal trial of Ryoncil®
Mesoblast and BMT CTN to initiate pivotal trial of Ryoncil®
MESOBLAST AND BMT CTN TO INITIATE PIVOTAL TRIAL OF RYONCIL® AS PART OF FIRST-LINE REGIMEN IN ADULTS WITH SEVERE ACUTE GVHD REFRACTORY TO STEROIDS
Download Go back to Newsroom
MESOBLAST AND BMT CTN TO INITIATE PIVOTAL TRIAL OF RYONCIL® AS PART OF FIRST-LINE REGIMEN IN ADULTS WITH SEVERE ACUTE GVHD REFRACTORY TO STEROIDS